Search research articles
Contact Us
Filters
Showing results (441-450 of 463) with videos related to
Page
of 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Jenna L Koliani-Pace, Siddharth Singh, Michelle Luo, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis
Divya Jha, Zainab Al-Taie, Azra Krek, et al.
Gut
|
November 1, 2016
Development of an index to define overall disease severity in IBD
Corey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
Gastroenterology
|
May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease
Arthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 13, 2024
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus
Serre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, et al.
Journal of Crohn'S & Colitis
|
September 28, 2023
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Tenghao Zheng, Giulia Roda, Yamile Zabana, et al.
Gastroenterology
|
June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease
Parambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 463) with videos related to
Sort By:
Page
of 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Jenna L Koliani-Pace, Siddharth Singh, Michelle Luo, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis
Divya Jha, Zainab Al-Taie, Azra Krek, et al.
Gut
|
November 1, 2016
Development of an index to define overall disease severity in IBD
Corey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
Gastroenterology
|
May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease
Arthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 13, 2024
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus
Serre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, et al.
Journal of Crohn'S & Colitis
|
September 28, 2023
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Tenghao Zheng, Giulia Roda, Yamile Zabana, et al.
Gastroenterology
|
June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease
Parambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Page
of 47